What are the anti-allergic effects of enzymatically modified isoquercitrin, quercetin 3-O-glucoside, α-oligoglucosyl rutin, and quercetin in mice?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Enzymatically modified isoquercitrin (EMIQ) is the most effective compound in demonstrating anti-allergic effects in mice, due to its superior suppression of histamine release and inhibition of allergic reactions at lower doses. The anti-allergic effects of enzymatically modified isoquercitrin, quercetin 3-O-glucoside, α-oligoglucosyl rutin, and quercetin in mice are attributed to their ability to inhibit mast cell degranulation and the release of inflammatory mediators like histamine, as well as suppress the production of inflammatory cytokines 1. Key points to consider include:

  • EMIQ appears to be the most effective compound, showing superior suppression of histamine release and inhibition of allergic reactions at lower doses compared to the other compounds.
  • Quercetin 3-O-glucoside and α-oligoglucosyl rutin also exhibit anti-allergic properties but typically require higher doses to achieve similar effects.
  • Pure quercetin, while effective in theory, has limited bioavailability which reduces its practical effectiveness.
  • The superior effect of EMIQ is likely due to its enhanced bioavailability and absorption in the intestinal tract compared to the other forms.
  • These flavonoids represent promising natural compounds for managing allergic conditions, though their effects in mice may not directly translate to identical outcomes in humans. It is essential to note that while these compounds show promise, the current evidence is based on studies in mice, and more research is needed to confirm their effectiveness in humans, as highlighted by the guidelines for allergen immunotherapy 1.

From the Research

Anti-Allergic Effects of Enzymatically Modified Isoquercitrin and Related Compounds

The anti-allergic effects of enzymatically modified isoquercitrin (α-oligoglucosyl quercetin 3-O-glucoside), quercetin 3-O-glucoside, α-oligoglucosyl rutin, and quercetin have been studied in mice. The key findings are:

  • Enzymatically modified isoquercitrin (EMIQ) exhibited a significant inhibitory effect on the murine ear passive cutaneous anaphylaxis (PCA) reaction 2.
  • Quercetin 3-O-glucoside (isoquercitrin, IQC) and α-oligoglucosyl rutin (αOR) showed less or no anti-allergic effect compared to EMIQ 2.
  • The water solubility of these substances may affect their biological activities, as IQC and quercetin cannot completely dissolve in water at the concentration used 2.
  • Glycosyl conjugation of quercetin with specific sugar motifs is an effective strategy to improve the biological activity of quercetin in vivo 2.

Mechanisms of Action

The mechanisms of action of these compounds involve:

  • Inhibition of histamine production and pro-inflammatory mediators 3.
  • Regulation of the Th1/Th2 balance and decrease of antigen-specific IgE antibody releasing by B cells 3.
  • Anti-inflammatory and immunomodulatory functions, making them suitable for the management of allergic diseases 3.

Related Studies

Other studies have investigated the anti-allergic effects of quercetin and its derivatives, including:

  • Quercetin's potential as a safe anti-allergic substance, although its use is limited by complex issues 4.
  • The anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma 5.
  • The pharmacology, toxicology, and metabolism of isoquercitrin, including its higher bioavailability and chemoprotective effects compared to quercetin 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Quercetin with the potential effect on allergic diseases.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2020

Research

Quercetin as a potential anti-allergic drug: which perspectives?

Iranian journal of allergy, asthma, and immunology, 2011

Research

Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma.

Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2007

Research

Isoquercitrin: pharmacology, toxicology, and metabolism.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.